Advertisement
Screener

PROMIS NEUROSCIENCES INC. (PMN) Shares Outstanding (Cover Page)

2.8 / 5 stars · 68/120 Roast Me

PROMIS NEUROSCIENCES INC. Shares Outstanding (Cover Page)

PROMIS NEUROSCIENCES INC. (PMN) had Shares Outstanding (Cover Page) of 8.97 million shares as of 2026-08-13, per its 10-Q filed 2026-08-13.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13

  • 2026-08-13: Entity Common Stock, Shares Outstanding 8.97M shares.
  • 2026-05-12: Entity Common Stock, Shares Outstanding 8.97M shares.
  • 2026-03-25: Entity Common Stock, Shares Outstanding 8.97M shares.
  • 2025-11-12: Entity Common Stock, Shares Outstanding 53.81M shares.
Period endEntity Common Stock, Shares Outstanding
2026-08-138.97M shares
10-Q · filed 2026-08-13
2026-05-128.97M shares
10-Q · filed 2026-05-12
2026-03-258.97M shares
10-K · filed 2026-03-25
2025-11-1253.81M shares
10-Q · filed 2025-11-12
2025-08-1351.81M shares
10-Q · filed 2025-08-13
2025-05-1232.69M shares
10-Q · filed 2025-05-12
2025-03-2932.69M shares
10-K · filed 2025-03-31
2024-11-1432.69M shares
10-Q · filed 2024-11-14
2024-08-0729.89M shares
10-Q · filed 2024-08-08
2024-05-1418.96M shares
10-Q · filed 2024-05-14
2024-03-2818.96M shares
10-K · filed 2024-04-01
2023-11-1018.89M shares
10-Q · filed 2023-11-14
2023-08-148.58M shares
10-Q · filed 2023-08-14
2023-05-158.58M shares
10-Q · filed 2023-05-15
2023-03-088.58M shares
10-K/A · filed 2023-04-27
2022-11-068.58M shares
10-Q · filed 2022-11-14
2022-08-047.20M shares
10-Q · filed 2022-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51